title: Morphological and molecular changes of human granulosa cells exposed to 5-azacytidine and addressed toward muscular differentiation.
abstract: Converting adult cells from one cell type to another is a particularly interesting idea for regenerative medicine. Terminally differentiated cells can be induced to de-differentiate in vitro to become multipotent progenitors. In mammals these changes do not occur naturally, however exposing differentiated adult cells to synthetic molecules capable of selectively reverting cells from their lineage commitment to a more plastic state makes it possible to re-address their fate. Only scattered information are available on the morphological changes and ultrastructural remodeling taking place when cells convert into a different and specific type. To better clarify these aspects, we derived human granulosa cell (GC) primary cultures and analyzed the morphological changes taking place in response to the exposure to the epigenetic modifier 5-azacytidine (5-aza-CR) and to the treatment with VEGF, as a stimulus for inducing differentiation into muscle cells. Ultrastructural modifications and molecular marker expression were analyzed at different intervals during the treatments. Our results indicate that the temporary up regulation of pluripotency markers is accompanied by the loss of GC-specific ultrastructural features, mainly through autophagocitosis, and is associated with a temporary chromatin decondensation. After exposure to VEGF the induction of muscle specific genes was combined with the appearance of multinucleated cells with a considerable quantity of non-spatially organized filaments. The detailed analysis of the morphological changes occurring in cells undergoing lineage re-addressing allows a better understanding of these process and may prove useful for refining the use of somatic cells in regenerative medicine and tissue replacement therapies.
authors.affiliation: Laboratory of Biomedical Embryology, Centre for Stem Cell Research, University of Milan, via Celoria 10, 20133, Milan, Italy, tiziana.brevini@unimi.it.
authors.forename: Tiziana A L
authors.initials: TA
authors.lastname: Brevini
authors.forename: Georgia
authors.initials: G
authors.lastname: Pennarossa
authors.forename: Mahbubur M
authors.initials: MM
authors.lastname: Rahman
authors.forename: Alessio
authors.initials: A
authors.lastname: Paffoni
authors.forename: Stefania
authors.initials: S
authors.lastname: Antonini
authors.forename: Guido
authors.initials: G
authors.lastname: Ragni
authors.forename: Magda
authors.initials: M
authors.lastname: deEguileor
authors.forename: Gianluca
authors.initials: G
authors.lastname: Tettamanti
authors.forename: Fulvio
authors.initials: F
authors.lastname: Gandolfi
mesh_terms: D001374:Azacitidine / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects*; D002478:Cells, Cultured; D005260:Female; D006107:Granulosa Cells / Q000166:cytology* / Q000187:drug effects*; D006801:Humans; D009132:Muscles / Q000166:cytology* / Q000187:drug effects*
chemical_list: D001374:Azacitidine